Rituximab, lenalidomide, and ibrutinib in relapsed/refractory primary cutaneous diffuse large B-cell lymphoma, leg type.
Br J Haematol
; 196(4): e30-e33, 2022 02.
Article
in En
| MEDLINE
| ID: mdl-34642938
Full text:
1
Database:
MEDLINE
Main subject:
Piperidines
/
Adenine
/
Antineoplastic Combined Chemotherapy Protocols
/
Lymphoma, Large B-Cell, Diffuse
/
Rituximab
/
Lenalidomide
/
Leg
Limits:
Aged
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Br J Haematol
Year:
2022
Type:
Article
Affiliation country:
United States